These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 10676686)

  • 21. Effect of direct stenting on clinical outcome in patients treated with percutaneous coronary intervention on saphenous vein graft.
    Leborgne L; Cheneau E; Pichard A; Ajani A; Pakala R; Yazdi H; Satler L; Kent K; Suddath WO; Pinnow E; Canos D; Waksman R
    Am Heart J; 2003 Sep; 146(3):501-6. PubMed ID: 12947370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thrombus predicts ischemic complications during percutaneous coronary intervention in saphenous vein grafts: results from TARGET (do Tirofiban and ReoPro give similar efficacy trial?).
    Kalyanasundaram A; Blankenship JC; Berger P; Herrmann H; McClure R; Moliterno D
    Catheter Cardiovasc Interv; 2007 Apr; 69(5):623-9. PubMed ID: 17192960
    [TBL] [Abstract][Full Text] [Related]  

  • 23. External stenting of saphenous vein grafts for coronary artery bypass: a single-center analysis of clinical outcomes.
    Sandner S; Angleitner P; Netuschill C; Stasek S; Manville E; Siller-Matula J; Laufer G; Zimpfer D
    J Cardiovasc Surg (Torino); 2022 Apr; 63(2):187-194. PubMed ID: 35005876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of sirolimus-eluting stents as compared to paclitaxel-eluting stents for saphenous vein graft intervention.
    Chu WW; Kuchulakanti PK; Wang B; Clavijo LC; Suddath WO; Pichard AD; Satler LF; Kent KM; Waksman R
    J Interv Cardiol; 2006 Apr; 19(2):121-5. PubMed ID: 16650239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Five-year follow-up of the plaque sealing with paclitaxel-eluting stents vs medical therapy for the treatment of intermediate nonobstructive saphenous vein graft lesions (VELETI) trial.
    Rodés-Cabau J; Bertrand OF; Larose E; Déry JP; Rinfret S; Urena M; Jerez M; Nombela-Franco L; Ribeiro HB; Allende R; Proulx G; Nguyen CM; Boudreault JR; Rouleau J; Roy L; Gleeton O; Barbeau G; Noël B; Côté M; Després JP; Dagenais GR; DeLarochellière R
    Can J Cardiol; 2014 Jan; 30(1):138-45. PubMed ID: 24365196
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term outcome following percutaneous coronary intervention with drug-eluting stents compared with bare-metal stents in saphenous vein graft lesions: from Western Denmark Heart Registry.
    Hougaard M; Thayssen P; Kaltoft A; Tilsted HH; Maeng M; Lassen JF; Thuesen L; Okkels Jensen L
    Catheter Cardiovasc Interv; 2014 Jun; 83(7):1035-42. PubMed ID: 24311384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term clinical results after stent implantation in old obstructed saphenous vein grafts.
    Ribeiro PA; Scavetta K; Oh C; Al-Zaibag M; Jutzy KR; Caldron R; Marsa RJ
    Chest; 2000 Sep; 118(3):750-5. PubMed ID: 10988198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes after implantation of the TAXUS paclitaxel-eluting stent in saphenous vein graft lesions: results from the ARRIVE (TAXUS Peri-Approval Registry: A Multicenter Safety Surveillance) program.
    Brilakis ES; Lasala JM; Cox DA; Berger PB; Bowman TS; Starzyk RM; Dawkins KD
    JACC Cardiovasc Interv; 2010 Jul; 3(7):742-50. PubMed ID: 20650436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug-eluting stenting is superior to bare metal stenting in saphenous vein grafts.
    Lee MS; Shah AP; Aragon J; Jamali A; Dohad S; Kar S; Makkar RR
    Catheter Cardiovasc Interv; 2005 Dec; 66(4):507-11. PubMed ID: 16270361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug-eluting stenting of saphenous vein graft versus native coronary artery supplying the same myocardial perfusion territory: a pilot retrospective 3-year follow-up.
    Ho PC; Lee AC; Fortuna R
    J Invasive Cardiol; 2012 Oct; 24(10):516-20. PubMed ID: 23043035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Late myocardial ischemic events after saphenous vein graft intervention--importance of initially "nonsignificant" vein graft lesions.
    Ellis SG; Brener SJ; DeLuca S; Tuzcu EM; Raymond RE; Whitlow PL; Topol EJ
    Am J Cardiol; 1997 Jun; 79(11):1460-4. PubMed ID: 9185633
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug-eluting stents compared with bare metal stents improve late outcome after saphenous vein graft but not after large native vessel interventions.
    Jeger RV; Schneiter S; Kaiser C; Bonetti PO; Brunner-La Rocca H; Handke M; Osswald S; Buser PT; Pfisterer ME;
    Cardiology; 2009; 112(1):49-55. PubMed ID: 18580059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized evaluation of polytetrafluoroethylene-covered stent in saphenous vein grafts: the Randomized Evaluation of polytetrafluoroethylene COVERed stent in Saphenous vein grafts (RECOVERS) Trial.
    Stankovic G; Colombo A; Presbitero P; van den Branden F; Inglese L; Cernigliaro C; Niccoli L; Bartorelli AL; Rubartelli P; Reifart N; Heyndrickx GR; Saunamäki K; Morice MC; Sgura FA; Di Mario C;
    Circulation; 2003 Jul; 108(1):37-42. PubMed ID: 12821546
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of diabetes mellitus on long-term clinical outcomes after percutaneous coronary saphenous vein graft interventions in the drug-eluting stent era.
    Pendyala LK; Loh JP; Kitabata H; Minha S; Torguson R; Chen F; Satler LF; Suddath WO; Pichard AD; Waksman R
    J Interv Cardiol; 2014 Aug; 27(4):391-8. PubMed ID: 25059286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Randomized Trial of External Stenting for Saphenous Vein Grafts in Coronary Artery Bypass Grafting.
    Taggart DP; Ben Gal Y; Lees B; Patel N; Webb C; Rehman SM; Desouza A; Yadav R; De Robertis F; Dalby M; Banning A; Channon KM; Di Mario C; Orion E
    Ann Thorac Surg; 2015 Jun; 99(6):2039-45. PubMed ID: 25886810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of saphenous vein bypass grafts with ultrasound thrombolysis: a randomized study (ATLAS).
    Singh M; Rosenschein U; Ho KK; Berger PB; Kuntz R; Holmes DR
    Circulation; 2003 May; 107(18):2331-6. PubMed ID: 12732601
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Procedural results and late clinical outcomes after percutaneous interventions using long (> or = 25 mm) versus short (< 20 mm) stents.
    Kornowski R; Bhargava B; Fuchs S; Lansky AJ; Satler LF; Pichard AD; Hong MK; Kent KM; Mehran R; Stone GW; Leon MB
    J Am Coll Cardiol; 2000 Mar; 35(3):612-8. PubMed ID: 10716462
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of debulking followed by stenting versus stenting alone for saphenous vein graft aortoostial lesions: immediate and one-year clinical outcomes.
    Ahmed JM; Hong MK; Mehran R; Mintz GS; Lansky AJ; Pichard AD; Satler LF; Kent KM; Wu H; Stone GW; Leon MB
    J Am Coll Cardiol; 2000 May; 35(6):1560-8. PubMed ID: 10807461
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and angiographic efficacy of a self-expanding nitinol stent in saphenous vein graft atherosclerotic disease: the Stent Comparative Restenosis (SCORES) Saphenous Vein Graft Registry.
    Kandzari DE; Goldberg S; Schwartz RS; Chazin-Caldie M; Sketch MH;
    Am Heart J; 2003 May; 145(5):868-74. PubMed ID: 12766746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and angiographic outcomes after percutaneous recanalization of chronic total saphenous vein graft occlusion using modern techniques.
    Al-Lamee R; Ielasi A; Latib A; Godino C; Ferraro M; Arioli F; Mussardo M; Piraino D; Figini F; Carlino M; Montorfano M; Chieffo A; Colombo A
    Am J Cardiol; 2010 Dec; 106(12):1721-7. PubMed ID: 21126616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.